on-pharmacological management of breathlessness: a randomised controlled trial of different intensity training

Hull and East Yorkshire Hospitals NHS Trust (UK)0 个研究点目标入组 40 人开始时间: 2009年3月5日最近更新: 2020年4月6日

适应症

试验速览

•1. Intractable breathlessness resulting from primary or secondary malignant lung disease in the palliative setting where the underlying cause has been maximally treated
•2. All identified reversible causes of the breathlessness have been treated if appropriate to do so, in the opinion of the attending clinician
•3. Karnofsky Performance Status (KPS) greater than 40%
•4. Aged greater than 18 years, either sex
•5. Willingness to attend for breathlessness training
•6. Ability to give informed consent
•7. Expected prognosis of at least 3 months in the opinion of the attending clinician

•1. Inability to give informed consent
•2. Intercurrent illness or co-morbidities making completion of the physiotherapy breathlessness course (PBC) course unlikely
•3. Rapidly worsening breathlessness requiring urgent medical intervention
•4. Palliative radiotherapy to chest in previous 4 weeks
•5. Radical radiotherapy in previous 6 months
•6. Chemotherapy or change in anti-cancer hormone treatment in previous 2 weeks

发起方

Hull and East Yorkshire Hospitals NHS Trust (UK)